Clarification from AHA would be most helpful as the coding clinic contradicts the code that was specifically classified for long-term use of these meds in Appendix A
Clinical studies demonstrate that GLP-1 medicines can reduce visceral adipose tissue as part of overall weight loss, offering potential benefits for cardiovascular and metabolic health
True recovery, whether from weight gain, metabolic syndrome, or chronic inflammatory conditions, must come from addressing the whole terrain : Detoxification, immune rebalancing, mitochondrial health, hormonal regulation, nervous system calming, and sustainable lifestyle shifts
You can either use your existing doctor, find a provider through Strive network, or use a telehealth platform that works with Strive